Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Roboz

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Immunology Letters|January 1, 1988
Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI)P H Tsang, J P Roboz, J F Holland, et al.
Pediatric Research|September 1, 1995
Increased expression of activation markers on CD8 lymphocytes in children with human immunodeficiency virus-1 infectionM Schlesinger, V Peters, J D Jiang, et al.
The Mount Sinai Journal of Medicine, New York|February 1, 1987
Immune dysfunctions and therapeutic interventions in patients with acquired immune deficiency syndrome and AIDS-related complexP H Tsang, J I Wallace, J P Roboz, et al.
The Journal of Infectious Diseases|July 1, 1991
Human immunodeficiency virus type 1 (HIV-1) genomic sequences and distinct changes in CD8+ lymphocytes precede detectable levels of HIV-1 antibodies in high-risk homosexualsM J Yagi, M E Joesten, J Wallace, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Functional integrity of T, B, and natural killer cells in homosexual subjects with prodromata and in patients with AIDSJ G Bekesi, P Tsang, F Lew, et al.
Journal of Clinical Immunology|March 1, 1997
Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical statusJ D Jiang, M Schlesinger, H Sacks, et al.
Clinical Immunology and Immunopathology|February 1, 1993
Phenotypic aberrations of CD3+ and CD4+ cells and functional impairments of lymphocytes at low-level occupational exposure to leadA Fischbein, P Tsang, J C Luo, et al.
Journal of Clinical Immunology|November 1, 1988
Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind studyY Sei, P H Tsang, J P Roboz, et al.
Biochemical Pharmacology|November 15, 2000
3-m-bromoacetylamino benzoic acid ethyl ester: a new cancericidal agent that activates the apoptotic pathway through caspase-9M Schlesinger, J D Jiang, J P Roboz, et al.
Clinical Immunology and Immunopathology|November 1, 1994
A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individualsM Schlesinger, F N Chu, M Badamchian, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Immunology Letters|January 1, 1988
Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI)P H Tsang, J P Roboz, J F Holland, et al.
Pediatric Research|September 1, 1995
Increased expression of activation markers on CD8 lymphocytes in children with human immunodeficiency virus-1 infectionM Schlesinger, V Peters, J D Jiang, et al.
The Mount Sinai Journal of Medicine, New York|February 1, 1987
Immune dysfunctions and therapeutic interventions in patients with acquired immune deficiency syndrome and AIDS-related complexP H Tsang, J I Wallace, J P Roboz, et al.
The Journal of Infectious Diseases|July 1, 1991
Human immunodeficiency virus type 1 (HIV-1) genomic sequences and distinct changes in CD8+ lymphocytes precede detectable levels of HIV-1 antibodies in high-risk homosexualsM J Yagi, M E Joesten, J Wallace, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Functional integrity of T, B, and natural killer cells in homosexual subjects with prodromata and in patients with AIDSJ G Bekesi, P Tsang, F Lew, et al.
Journal of Clinical Immunology|March 1, 1997
Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical statusJ D Jiang, M Schlesinger, H Sacks, et al.
Clinical Immunology and Immunopathology|February 1, 1993
Phenotypic aberrations of CD3+ and CD4+ cells and functional impairments of lymphocytes at low-level occupational exposure to leadA Fischbein, P Tsang, J C Luo, et al.
Journal of Clinical Immunology|November 1, 1988
Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind studyY Sei, P H Tsang, J P Roboz, et al.
Biochemical Pharmacology|November 15, 2000
3-m-bromoacetylamino benzoic acid ethyl ester: a new cancericidal agent that activates the apoptotic pathway through caspase-9M Schlesinger, J D Jiang, J P Roboz, et al.
Clinical Immunology and Immunopathology|November 1, 1994
A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individualsM Schlesinger, F N Chu, M Badamchian, et al.
Pageof 3